AMED Latest Quarter's Earnings
Announce Date 07/29/2025
EPS Normalized Actual $1.54 (Beat by $0.15)
EPS GAAP Actual $1.54 (Beat by $0.15)
Revenue Actual $0.621861B
Revenue Surprise Beat by $621.861M
Upcoming Quarter's Earnings
Announce Date 07/01/2025 (Pre-Market)
EPS Normalized Estimate $1.3125
EPS GAAP Estimate $1.3125
Revenue Estimate $0.60996325B
Annual EPS Estimate
Fiscal Period Ending EPS Estimate Forward PE Low High # of Analysts
Dec 2027 5.25 19.23 5.12123 5.79102 1
Dec 2026 4.53 22.28 4.41488 4.67198 1
Quarterly EPS History
Period EPS Beat / Miss Revenue YoY Beat / Miss
FQ2 2025 (Jun 2025) 2.06 0.77333 0.621861B 4.93% 8.91M
FQ1 2025 (Mar 2025) 1.86 0.78 0.594781B 3.93% -10.6M
FQ4 2024 (Dec 2024) -0.62 -1.80844 0.598052B 4.56% -2.03M
FQ3 2024 (Sep 2024) 1.27 1.27 0.587671B 5.35% 587.67M
FQ2 2024 (Jun 2024) 2.01 2.01 0.591187B 6.46% 591.19M
FQ1 2024 (Mar 2024) 1.22 1.22 0.571414B 2.63% 571.41M
FQ4 2023 (Dec 2023) 1.2 1.2 0.570788B 1.53% 570.79M
FQ3 2023 (Sep 2023) 0.8 0.8 0.556237B -0.31% 556.24M
Quarterly Estimates Summary

FQ4 Announce Date

07/01/2025 (Pre-Market)

Consensus EPS Estimates

1.3125

Consensus Revenue Estimates

0.60996325B

Consensus EPS Estimates
Fiscal Period Ending EPS Estimate YoY Growth(%) Low High # of Analysts
FQ4 2027 (Dec 2027) 1.3 -- 1.28283 1.31539 7
FQ3 2027 (Sep 2027) 1.4 -- 1.38151 1.41658 4
FQ2 2027 (Jun 2027) 1.42 -- 1.40124 1.43681 3
FQ1 2027 (Mar 2027) 1.37 -- 1.3519 1.38622 7
FQ4 2026 (Dec 2026) 1.29216 -- 1.27197 1.31825 4
FQ3 2026 (Sep 2026) 1.34658 -- 1.32554 1.37377 3
FQ2 2026 (Jun 2026) 1.51063 -36.37 1.48702 1.54113 4
FQ1 2026 (Mar 2026) 1.25636 -48.05 1.23673 1.28173 3
FQ4 2025 (Oct 2025) 1.22 150.82 1.20144 1.24537 4
Consensus Revenue Estimates
Fiscal Period Ending Revenue Estimate YoY Growth(%) Low High # of Analysts
FQ4 2027 (Dec 2027) 0.69B -- 0.68B 0.7B 5
FQ3 2027 (Sep 2027) 0.68B -- 0.68B 0.69B 5
FQ2 2027 (Jun 2027) 0.68B -- 0.68B 0.69B 5
FQ1 2027 (Mar 2027) 0.66B -- 0.65B 0.67B 5
FQ4 2026 (Dec 2026) 0.69B -- 0.69B 0.7B 3
FQ3 2026 (Sep 2026) 0.68B -- 0.67B 0.69B 3
FQ2 2026 (Jun 2026) 0.67B 7.65 0.67B 0.68B 4
FQ1 2026 (Mar 2026) 0.66B 9.77 0.65B 0.67B 5
FQ4 2025 (Oct 2025) 0.62B 3.13 0.61B 0.63B 3
Quarterly Estimates Revisions

EPS # of Up Revisions

4

EPS # of Down Revisions

4

Revenue # of Up Revisions

6

Revenue # of Down Revisions

3

Consensus EPS Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Consensus Revenue Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Earnings Surprise Summary

EPS # of Beats

7

EPS # of Misses

1

EPS # of in-lines

0

Revenue # of Beats

6

Revenue # of Misses

2

Revenue # of in-lines

0

Earnings Surprise (EPS) - Actual vs Consensus
Earnings Date EPS Estimate EPS Actual Surprise Surprise %
FQ2 2025 (Jun 2025) 1.28667 2.06 0.77333 37.54%
FQ1 2025 (Mar 2025) 1.08 1.86 0.78 41.94%
FQ4 2024 (Dec 2024) 1.18844 -0.62 -1.80844 291.68%
FQ3 2024 (Sep 2024) 1.27 1.27 100%
FQ2 2024 (Jun 2024) 2.01 2.01 100%
FQ1 2024 (Mar 2024) 1.22 1.22 100%
FQ4 2023 (Dec 2023) 1.2 1.2 100%
FQ3 2023 (Sep 2023) 0.8 0.8 100%
Revenue Surprise - Actual vs Consensus
Earnings Date Revenue Estimate Revenue Actual Surprise Surprise %
FQ2 2025 (Jun 2025) $0.61B $0.62B $8.91M 1.43%
FQ1 2025 (Mar 2025) $0.61B $0.59B $-10.6M -1.78%
FQ4 2024 (Dec 2024) $0.6B $0.6B $-2.03M -0.34%
FQ3 2024 (Sep 2024) $0B $0.59B $587.67M 100%
FQ2 2024 (Jun 2024) $0B $0.59B $591.19M 100%
FQ1 2024 (Mar 2024) $0B $0.57B $571.41M 100%
FQ4 2023 (Dec 2023) $0B $0.57B $570.79M 100%
FQ3 2023 (Sep 2023) $0B $0.56B $556.24M 100%
Unlock